Metabolite

KNApSAcK Entry

id C00026478
Name Quinoline
CAS RN 91-22-5
Standard InChI InChI=1S/C9H7N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-7H
Standard InChI (Main Layer) InChI=1S/C9H7N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-7H

Cluster

Phytochemical cluster
KCF-S cluster No. 4717

Link

ChEMBL

By standard InChI CHEMBL14474
By standard InChI Main Layer CHEMBL14474

KEGG

By LinkDB C06413

CTD

By CAS RN C037219

Species

Summary

Plant class

class name count

Family

family name count
Diapheromeridae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Oreophoetes peruana 173814 Diapheromeridae Metazoa

Human Protein / Gene in interaction

6 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P10635 Cytochrome P450 2D6 Cytochrome P450 2D6 CHEMBL14474 CHEMBL729206 (1)
1 / 0
Q9HAW8 UDP-glucuronosyltransferase 1-10 Enzyme CHEMBL14474 CHEMBL1908087 (1)
0 / 0
P37840 Alpha-synuclein Unclassified protein CHEMBL14474 CHEMBL2354282 (1)
4 / 2
P00352 Retinal dehydrogenase 1 Enzyme CHEMBL14474 CHEMBL1614458 (1)
0 / 0
Q9HAW9 UDP-glucuronosyltransferase 1-8 Enzyme CHEMBL14474 CHEMBL1908085 (1)
0 / 0
Q9UNA4 DNA polymerase iota Enzyme CHEMBL14474 CHEMBL1794483 (1)
0 / 0

CTD interaction (76)

compound gene gene name gene description interaction interaction type form reference
pmid
C037219 11332 ACOT7
ACH1
ACT
BACH
CTE-II
LACH
LACH1
RP1-120G22.10
hBACH
acyl-CoA thioesterase 7 (EC:3.1.2.2) quinoline analog results in increased expression of ACOT7 protein increases expression
protein 18645022
C037219 199 AIF1
AIF-1
IBA1
IRT-1
IRT1
allograft inflammatory factor 1 quinoline analog results in increased activity of AIF1 protein increases activity
protein 18645022
C037219 8125 ANP32A
C15orf1
HPPCn
I1PP2A
LANP
MAPM
PHAP1
PHAPI
PP32
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A quinoline analog results in decreased expression of ANP32A protein decreases expression
protein 18645022
C037219 301 ANXA1
ANX1
LPC1
annexin A1 quinoline analog results in increased expression of ANXA1 protein increases expression
protein 18645022
C037219 302 ANXA2
ANX2
ANX2L4
CAL1H
LIP2
LPC2
LPC2D
P36
PAP-IV
annexin A2 quinoline analog results in increased expression of ANXA2 protein increases expression
protein 18645022
C037219 689 BTF3
BETA-NAC
BTF3a
BTF3b
NACB
basic transcription factor 3 quinoline analog results in decreased expression of BTF3 protein decreases expression
protein 18645022
C037219 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) quinoline analog results in increased cleavage of and results in increased activity of CASP3 protein increases activity
/ increases cleavage
protein 18645022
C037219 11335 CBX3
HECH
HP1-GAMMA
HP1Hs-gamma
chromobox homolog 3 quinoline analog results in decreased expression of CBX3 protein decreases expression
protein 18645022
C037219 891 CCNB1
CCNB
cyclin B1 quinoline analog results in increased expression of CCNB1 protein increases expression
protein 18645022
C037219 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) quinoline analog results in increased expression of CDKN1A protein increases expression
protein 18645022
C037219 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) [quinoline analog results in increased expression of TP53 protein] which results in increased expression of CDKN1A protein increases expression
protein 18645022
C037219 1029 CDKN2A
ARF
CDK4I
CDKN2
CMM2
INK4
INK4A
MLM
MTS-1
MTS1
P14
P14ARF
P16
P16-INK4A
P16INK4
P16INK4A
P19
P19ARF
TP16
cyclin-dependent kinase inhibitor 2A quinoline analog results in decreased methylation of CDKN2A promoter decreases methylation
promoter 19417133
C037219 1029 CDKN2A
ARF
CDK4I
CDKN2
CMM2
INK4
INK4A
MLM
MTS-1
MTS1
P14
P14ARF
P16
P16-INK4A
P16INK4
P16INK4A
P19
P19ARF
TP16
cyclin-dependent kinase inhibitor 2A quinoline analog results in increased expression of CDKN2A mRNA increases expression
mRNA 19417133
C037219 1029 CDKN2A
ARF
CDK4I
CDKN2
CMM2
INK4
INK4A
MLM
MTS-1
MTS1
P14
P14ARF
P16
P16-INK4A
P16INK4
P16INK4A
P19
P19ARF
TP16
cyclin-dependent kinase inhibitor 2A quinoline analog results in increased expression of CDKN2A protein increases expression
protein 19417133
C037219 55748 CNDP2
CN2
CPGL
HsT2298
PEPA
CNDP dipeptidase 2 (metallopeptidase M20 family) (EC:3.4.13.18) quinoline analog results in increased expression of CNDP2 protein increases expression
protein 18645022
C037219 7812 CSDE1
D1S155E
RP5-1000E10.3
UNR
cold shock domain containing E1, RNA-binding quinoline analog results in increased expression of CSDE1 protein increases expression
protein 18645022
C037219 1544 CYP1A2
CP12
P3-450
P450(PA)
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) quinoline analog results in decreased activity of CYP1A2 protein decreases activity
protein 15916432
C037219 1548 CYP2A6
CPA6
CYP2A
CYP2A3
CYPIIA6
P450C2A
P450PB
cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) CYP2A6 protein results in increased metabolism of quinoline increases metabolic processing
protein 8824525
C037219 1571 CYP2E1
CPE1
CYP2E
P450-J
P450C2E
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) CYP2E1 protein results in increased hydroxylation of quinoline increases hydroxylation
protein 8824525
C037219 1786 DNMT1
ADCADN
AIM
CXXC9
DNMT
HSN1E
MCMT
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [quinoline analog results in increased degradation of DNMT1 protein] decreases reaction
/ increases degradation
protein 19417133
C037219 1786 DNMT1
ADCADN
AIM
CXXC9
DNMT
HSN1E
MCMT
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) quinoline analog results in increased degradation of DNMT1 protein increases degradation
protein 19417133
C037219 1869 E2F1
E2F-1
RBAP1
RBBP3
RBP3
E2F transcription factor 1 quinoline analog affects the expression of E2F1 protein affects expression
protein 15450938
C037219 1937 EEF1G
EF1G
GIG35
eukaryotic translation elongation factor 1 gamma quinoline analog results in increased expression of EEF1G protein increases expression
protein 18645022
C037219 1938 EEF2
EEF-2
EF-2
EF2
SCA26
eukaryotic translation elongation factor 2 quinoline analog results in decreased expression of EEF2 protein decreases expression
protein 18645022
C037219 2149 F2R
CF2R
HTR
PAR-1
PAR1
TR
coagulation factor II (thrombin) receptor quinoline analog binds to and results in decreased activity of F2R protein affects binding
/ decreases activity
protein 16380251
C037219 6624 FSCN1
FAN1
HSN
SNL
p55
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) quinoline analog results in increased expression of FSCN1 protein increases expression
protein 18645022
C037219 8880 FUBP1
FBP
FUBP
far upstream element (FUSE) binding protein 1 quinoline analog results in decreased expression of FUBP1 protein decreases expression
protein 18645022
C037219 3191 HNRNPL
HNRPL
hnRNP-L
heterogeneous nuclear ribonucleoprotein L quinoline analog results in decreased expression of HNRNPL protein decreases expression
protein 18645022
C037219 79256 quinoline analog results in decreased expression of HNRPD protein decreases expression
protein 18645022
C037219 3678 ITGA5
CD49e
FNRA
VLA5A
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) quinoline analog binds to and results in decreased activity of [ITGA5 protein binds to ITGB3 protein] affects binding
/ decreases activity
protein 16984141
C037219 3690 ITGB3
BDPLT16
BDPLT2
CD61
GP3A
GPIIIa
GT
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) quinoline analog binds to and results in decreased activity of [ITGA5 protein binds to ITGB3 protein] affects binding
/ decreases activity
protein 16984141
C037219 3958 LGALS3
CBP35
GAL3
GALBP
GALIG
L31
LGALS2
MAC2
lectin, galactoside-binding, soluble, 3 quinoline analog results in increased expression of LGALS3 protein increases expression
protein 18645022
C037219 4000 LMNA
CDCD1
CDDC
CMD1A
CMT2B1
EMD2
FPL
FPLD
FPLD2
HGPS
IDC
LDP1
LFP
LGMD1B
LMN1
LMNC
LMNL1
PRO1
lamin A/C quinoline analog results in decreased expression of LMNA protein decreases expression
protein 18645022
C037219 4000 LMNA
CDCD1
CDDC
CMD1A
CMT2B1
EMD2
FPL
FPLD
FPLD2
HGPS
IDC
LDP1
LFP
LGMD1B
LMN1
LMNC
LMNL1
PRO1
lamin A/C quinoline analog results in increased expression of LMNA protein increases expression
protein 18645022
C037219 4048 LTA4H
leukotriene A4 hydrolase (EC:3.3.2.6) quinoline analog results in increased expression of LTA4H protein increases expression
protein 18645022
C037219 5604 MAP2K1
CFC3
MAPKK1
MEK1
MKK1
PRKMK1
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) quinoline results in decreased activity of MAP2K1 protein decreases activity
protein 18393446
C037219 1326 MAP3K8
COT
EST
ESTF
MEKK8
TPL2
Tpl-2
c-COT
mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25) quinoline analog results in decreased activity of MAP3K8 protein decreases activity
protein 16973359
C037219 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) quinoline analog inhibits the reaction [ZAK protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]] decreases reaction
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 15737997
C037219 5599 MAPK8
JNK
JNK-46
JNK1
JNK1A2
JNK21B1/2
PRKM8
SAPK1
SAPK1c
mitogen-activated protein kinase 8 (EC:2.7.11.24) quinoline analog results in decreased phosphorylation of and results in decreased activity of MAPK8 protein decreases activity
/ decreases phosphorylation
protein 15737997
C037219 4292 MLH1
COCA2
FCC2
HNPCC
HNPCC2
hMLH1
mutL homolog 1 quinoline analog results in increased expression of MLH1 mRNA increases expression
mRNA 19417133
C037219 10797 MTHFD2
NMDMC
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (EC:3.5.4.9 1.5.1.15) quinoline analog results in decreased expression of MTHFD2 protein decreases expression
protein 18645022
C037219 4666 NACA
NACA1
nascent polypeptide-associated complex alpha subunit (EC:5.3.99.3) quinoline analog results in decreased expression of NACA protein decreases expression
protein 18645022
C037219 10135 NAMPT
1110035O14Rik
PBEF
PBEF1
VF
VISFATIN
nicotinamide phosphoribosyltransferase (EC:2.4.2.12) quinoline analog results in increased expression of NAMPT protein increases expression
protein 18645022
C037219 4831 NME2
NDKB
NDPK-B
NDPKB
NM23-H2
NM23B
PUF
NME/NM23 nucleoside diphosphate kinase 2 (EC:2.7.4.6 2.7.13.3) quinoline analog results in increased expression of NME2 protein increases expression
protein 18645022
C037219 29789 OLA1
DOC45
GBP45
GTBP9
GTPBP9
Obg-like ATPase 1 quinoline analog results in decreased expression of OLA1 protein decreases expression
protein 18645022
C037219 10606 PAICS
ADE2
ADE2H1
AIRC
PAIS
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) quinoline analog results in increased expression of PAICS protein increases expression
protein 18645022
C037219 11333 PDAP1
HASPP28
PAP
PAP1
PDGFA associated protein 1 quinoline analog results in decreased expression of PDAP1 protein decreases expression
protein 18645022
C037219 5160 PDHA1
PDHA
PDHCE1A
PHE1A
pyruvate dehydrogenase (lipoamide) alpha 1 (EC:1.2.4.1) quinoline analog results in increased expression of PDHA1 protein increases expression
protein 18645022
C037219 5465 PPARA
NR1C1
PPAR
PPARalpha
hPPAR
peroxisome proliferator-activated receptor alpha quinoline analog binds to and affects the activity of PPARA protein affects activity
/ affects binding
protein 17610302
C037219 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma quinoline analog binds to and affects the activity of PPARG protein affects activity
/ affects binding
protein 17610302
C037219 5573 PRKAR1A
ACRDYS1
ADOHR
CAR
CNC
CNC1
PKR1
PPNAD1
PRKAR1
TSE1
protein kinase, cAMP-dependent, regulatory, type I, alpha (EC:2.7.11.1) quinoline analog results in increased expression of PRKAR1A protein increases expression
protein 18645022
C037219 11212 PROSC
proline synthetase co-transcribed homolog (bacterial) quinoline analog results in increased expression of PROSC protein increases expression
protein 18645022
C037219 5684 PSMA3
HC8
PSC3
proteasome (prosome, macropain) subunit, alpha type, 3 (EC:3.4.25.1) quinoline analog results in decreased expression of PSMA3 protein decreases expression
protein 18645022
C037219 5700 PSMC1
P26S4
S4
p56
proteasome (prosome, macropain) 26S subunit, ATPase, 1 quinoline analog results in increased expression of PSMC1 protein increases expression
protein 18645022
C037219 5705 PSMC5
S8
SUG-1
SUG1
TBP10
TRIP1
p45
p45/SUG
proteasome (prosome, macropain) 26S subunit, ATPase, 5 quinoline analog results in increased expression of PSMC5 protein increases expression
protein 18645022
C037219 5710 PSMD4
AF
AF-1
ASF
MCB1
Rpn10
S5A
pUB-R5
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 quinoline analog results in decreased expression of PSMD4 protein decreases expression
protein 18645022
C037219 5713 PSMD7
MOV34
P40
Rpn8
S12
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 quinoline analog results in increased expression of PSMD7 protein increases expression
protein 18645022
C037219 5902 RANBP1
HTF9A
RAN binding protein 1 quinoline analog results in decreased expression of RANBP1 protein decreases expression
protein 18645022
C037219 5955 RCN2
E6BP
ERC-55
ERC55
TCBP49
reticulocalbin 2, EF-hand calcium binding domain quinoline analog results in decreased expression of RCN2 protein decreases expression
protein 18645022
C037219 6240 RRM1
R1
RIR1
RR1
ribonucleotide reductase M1 (EC:1.17.4.1) quinoline analog results in decreased expression of RRM1 protein decreases expression
protein 18645022
C037219 1992 SERPINB1
EI
ELANH2
LEI
M/NEI
MNEI
PI-2
PI2
serpin peptidase inhibitor, clade B (ovalbumin), member 1 quinoline analog results in increased expression of SERPINB1 protein increases expression
protein 18645022
C037219 5268 SERPINB5
PI5
maspin
serpin peptidase inhibitor, clade B (ovalbumin), member 5 quinoline analog results in increased expression of SERPINB5 protein increases expression
protein 18645022
C037219 7078 TIMP3
HSMRK222
K222
K222TA2
SFD
TIMP metallopeptidase inhibitor 3 quinoline analog results in decreased methylation of TIMP3 promoter decreases methylation
promoter 19417133
C037219 7078 TIMP3
HSMRK222
K222
K222TA2
SFD
TIMP metallopeptidase inhibitor 3 quinoline analog results in increased expression of TIMP3 mRNA increases expression
mRNA 19417133
C037219 7078 TIMP3
HSMRK222
K222
K222TA2
SFD
TIMP metallopeptidase inhibitor 3 quinoline analog results in increased expression of TIMP3 protein increases expression
protein 19417133
C037219 51311 TLR8
CD288
toll-like receptor 8 quinoline analog results in increased phosphorylation of and results in increased activity of TLR8 protein increases activity
/ increases phosphorylation
protein 17868034
C037219 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor quinoline analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] decreases reaction
/ increases expression
protein 16973359
C037219 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 quinoline analog results in increased activity of TP53 protein increases activity
protein 12082016
C037219 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 quinoline analog results in increased expression of TP53 protein increases expression
protein 18645022
C037219 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 quinoline analog results in increased expression of TP53 protein mutant form increases expression
protein 18645022
C037219 7157 TP53
BCC7
LFS1
P53
TRP53
tumor protein p53 [quinoline analog results in increased expression of TP53 protein] which results in increased expression of CDKN1A protein increases expression
protein 18645022
C037219 81567 TXNDC5
ENDOPDI
ERP46
HCC-2
PDIA15
STRF8
UNQ364
thioredoxin domain containing 5 (endoplasmic reticulum) quinoline analog results in decreased expression of TXNDC5 protein decreases expression
protein 18645022
C037219 9948 WDR1
AIP1
NORI-1
WD repeat domain 1 quinoline analog results in increased expression of WDR1 protein increases expression
protein 18645022
C037219 4904 YBX1
BP-8
CSDA2
CSDB
DBPB
MDR-NF1
NSEP-1
NSEP1
YB-1
YB1
Y box binding protein 1 quinoline analog results in decreased expression of YBX1 protein decreases expression
protein 18645022
C037219 51776 ZAK
AZK
MLK7
MLT
MLTK
MRK
mlklak
pk
sterile alpha motif and leucine zipper containing kinase AZK (EC:2.7.11.25) quinoline analog inhibits the reaction [ZAK protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]] decreases reaction
/ increases activity
/ increases phosphorylation
/ increases reaction
protein 15737997
C037219 51776 ZAK
AZK
MLK7
MLT
MLTK
MRK
mlklak
pk
sterile alpha motif and leucine zipper containing kinase AZK (EC:2.7.11.25) quinoline analog results in decreased activity of ZAK protein decreases activity
protein 15737997

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (5)

OMIM preferred title UniProt
#127750 Dementia, lewy body; dlb P37840
#608902 Drug metabolism, poor, cyp2d6-related P10635
#168601 Parkinson disease 1, autosomal dominant; park1 P37840
#605543 Parkinson disease 4, autosomal dominant; park4 P37840
#168600 Parkinson disease, late-onset; pd P37840

KEGG DISEASE (2)

KEGG disease name UniProt
H00057 Parkinson's disease (PD) P37840 (related)
H00066 Lewy body dementia (LBD) P37840 (related)

Diseases related to CTD interactions

4 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D006528 C037219 Carcinoma, Hepatocellular marker/mechanism
598648
D006390 C037219 Hemangioendothelioma marker/mechanism
598648
D006394 C037219 Hemangiosarcoma marker/mechanism
598648
D009362 C037219 Neoplasm Metastasis marker/mechanism
598648